McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

How Real-World Evidence is Impacting Clinical Quality Measures

by McKesson Ventures | Nov 11, 2016 | Portfolio News

In a recent guest post for Electronic Health Reporter, SHYFT Analytics’ chief product officer Priya Sapra discusses how using real-world evidence (RWE) is essential to understanding and improving clinical quality measures. Healthcare organizations and biotech...

Medidata and SHYFT Analytics Form Commercial Partnership

by McKesson Ventures | Sep 7, 2016 | Press Releases

SHYFT Analytics and Medidata have announced a partnership that will increase access to healthcare data analytics in clinical trials. Using SHYFT’s intelligent analytics and Medidata’s clinical technology platform, the partnership will enable life sciences companies to...

McKesson Ventures Joins SHYFT Analytics Series B, Bets on Analytics for Pharma

by McKesson Ventures | Sep 1, 2016 | Portfolio News

McKesson Ventures is the latest company to invest in Series B financing for SHYFT Analytics Inc. McKesson Ventures joins Medidata Solutions Inc., Health Enterprise Partners, and Milestone Venture Partners in a funding campaign for SHYFT that has secured $12.5 million....

SHYFT Analytics Raises $12.5 Million in New Funding from Global Healthcare and Technology Leaders, led by McKesson Ventures and Medidata Solutions

by McKesson Ventures | Aug 30, 2016 | Press Releases

SHYFT Analytics, a provider of cloud data and analytics for the global life sciences industry, announced that the company has secured $12.5 million in Series B funding from McKesson Ventures, Medidata Solutions, and other healthcare and technology investors. SHYFT...
Page 2 of 2«12

Recent Posts

  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings